Literature DB >> 33234708

Symptoms, risk factors, diagnosis and treatment of urinary tract infections.

Rajanbir Kaur1, Rajinder Kaur2.   

Abstract

Urinary tract infection (UTI) is a common microbial infection found in all ages and sexes which involves inflammation of the urinary tract. These infections can range from simple bladder inflammation, that is, cystitis, to severe cases of uroseptic shock. UTI ranks as the number 1 infection that leads to a prescription of antibiotics after a doctor's visit. These infections are sometimes distressing and even life threatening, and both males (12%) and females (40%) have at least one symptomatic UTI throughout their lives. Diagnostic failures in case of bacterial infections are the main contributing factor in improper use of antibiotics, delay in treatment and low survival rate in septic conditions. So, early diagnosis and appropriate therapy with antibiotics are the most significant requirements for preventing complicated UTI conditions such as urosepsis. This review article summarises the symptoms of the UTIs and the associated risk factors to it. The various conventional and recent diagnostic methods were also discussed in this review, along with treatment therapies with or without antibiotics. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diagnostic microbiology; epidemiology; infectious diseases; microbiology; urinary tract infections

Mesh:

Substances:

Year:  2020        PMID: 33234708     DOI: 10.1136/postgradmedj-2020-139090

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Management of antibacterial therapy of infectious and inflammatory diseases of the urinary tract in children and regional peculiarities during the COVID-19 pandemic.

Authors:  Volodymyr Volodymyrovych Bezruk; Igor Dmytrovych Shkrobanets; Oleksii Serhiiovych Godovanets; Oleksandr Hryhorovych Buriak; Olga Ivanivna Pervozvanska; Ludmila Mykhailivna Honcharuk; Nina Ivanivna Voytkevich; Olena Victorivna Makarova; Oksana Ivanivna Yurkiv; Michael Ivanovych Sheremet; Mykhailo Mykhailovich Hresko; Mariya Ivanivna Velia; Svyatoslava Vasylivna Yurniuk; Maryna Dmytrivna Hresko; Tetiana Sergiivna Bulyk; Larysa Vasylyvna Rynzhuk
Journal:  J Med Life       Date:  2022-05

2.  The distribution of disease in the Republic of Suriname - A pharmacoepidemiological analysis using the claims database of the State Health Foundation of the year 2017.

Authors:  Vinoj H Sewberath Misser; Arti Shankar; Ashna Hindori-Mohangoo; Jeffrey Wickliffe; Maureen Lichtveld; Dennis R A Mans
Journal:  J Public Health Epidemiol       Date:  2021-11-30

Review 3.  Mechanisms of Resistance in Gram-Negative Urinary Pathogens: From Country-Specific Molecular Insights to Global Clinical Relevance.

Authors:  Branka Bedenić; Tomislav Meštrović
Journal:  Diagnostics (Basel)       Date:  2021-04-28

4.  Efficacy and safety of tailin formulation combined with continuous low-dose antibiotic therapy in patients with recurrent urinary tract infection: A multicenter, randomized, controlled clinical trial.

Authors:  Tonglu Li; Yingru Xu; Gang Yuan; Wen Lu; Guihua Jian; Xuezhong Gong
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.